VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $7,093,000 | +39.5% | 269,700 | +439.4% | 0.07% | +51.1% |
| Q4 2015 | $5,083,000 | -85.2% | 50,000 | -74.0% | 0.04% | -90.1% |
| Q3 2015 | $34,338,000 | +56.9% | 192,500 | +95.4% | 0.45% | +54.4% |
| Q2 2015 | $21,882,000 | -78.0% | 98,500 | -85.8% | 0.29% | -78.4% |
| Q4 2014 | $99,605,000 | -30.0% | 696,000 | -35.9% | 1.36% | -40.5% |
| Q3 2014 | $142,352,000 | +12.9% | 1,085,000 | +8.5% | 2.28% | +25.5% |
| Q2 2014 | $126,120,000 | – | 1,000,000 | – | 1.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |